Article info

Original research
Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies

Authors

  1. Correspondence to Dr Thomas A Waldmann; tawald{at}mail.nih.gov
View Full Text

Citation

Dubois SP, Miljkovic MD, Fleisher TA, et al
Short-course IL-15 given as a continuous infusion led to a massive expansion of effective NK cells: implications for combination therapy with antitumor antibodies

Publication history

  • Accepted March 16, 2021
  • First published April 21, 2021.
Online issue publication 
April 21, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.